Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Operating Leases (2019 - 2026)

Collegium Pharmaceutical has reported Operating Leases over the past 7 years, most recently at $4.1 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 25.4% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, down 25.4%, while the annual FY2025 figure was $4.1 million, 25.4% down from the prior year.
  • Operating Leases for Q4 2025 was $4.1 million at Collegium Pharmaceutical, down from $4.5 million in the prior quarter.
  • Over five years, Operating Leases peaked at $8.6 million in Q1 2021 and troughed at $4.1 million in Q4 2025.
  • A 5-year average of $6.5 million and a median of $6.5 million in 2023 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: dropped 7.36% in 2024 and later fell 25.4% in 2025.
  • Year by year, Operating Leases stood at $8.0 million in 2021, then dropped by 10.55% to $7.1 million in 2022, then decreased by 13.89% to $6.1 million in 2023, then decreased by 9.55% to $5.5 million in 2024, then fell by 25.4% to $4.1 million in 2025.
  • Business Quant data shows Operating Leases for COLL at $4.1 million in Q4 2025, $4.5 million in Q3 2025, and $4.9 million in Q2 2025.